Pharmathen was founded in 1969 in Athens, as a private pharmaceutical company, and initially focused on developing and marketing health care products, with a strong position in the field of generics. With three sophisticated research laboratories and two state of the art manufacturing facilities, Pharmathen is today a completely vertically integrated company, its activities extending from the development of pharmaceutical active ingredients, up to the distribution of the final product. Furthermore, recently the company also made its dynamic entrance into the field of innovative products. Our competitive edge is characterized by cost efficient development and production, creative marketing and added value customer service.

The company’s human resources include more than 850 people who work in the sectors of Research & Development (R&D), production and distribution of drugs to more than 85 countries worldwide. Today Pharmathen’s products are approved in all EU markets and distribution rights have been granted to the largest pharmaceutical companies in the world, particularly in Europe, the United States of America and Canada. Sales of Pharmathenproducts reached a total of €162 million in 2012, while each year the company invests more than 20 million Euros on researching and developing new products.